GotoPER - Physicians' Education Resource
Back to Home
Free CE/CMEVideo

Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer

Create AccountAlready Registered? Login Here

Release Date

July 11, 2025

Expiration Date

July 12, 2026

Credits

1.5 CME, NCPD

Specialties

Breast Cancer, General Oncology+3 more

Release Date: July 11, 2025

Expiration Date: July 11, 2026

Activity Overview

This educational activity is an archive of the live presentation held on May 31, 2025.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward physicians, nurses, NPs/PAs, and other HCPs involved in the treatment and management of breast cancer.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Integrate guideline-based biomarker testing recommendations to personalize care for patients with HR+/HER2– metastatic breast cancer (MBC)
  • Assess efficacy and safety data for current and emerging next-generation endocrine agents
  • Incorporate recent clinical evidence on the use of next-generation endocrine agents to develop personalized treatment plans for patients with HR+/HER2– MBC
  • Apply shared decision-making strategies to effectively manage adverse events and enhance treatment adherence in patients receiving next-generation endocrine agents
Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Lilly and Stemline Therapeutics, Inc.

Testimonial “All information pertains to the work that I do daily and the patients I see on a daily basis.”

Related Content

Course

Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer

Create Account